David Spigel has been appointed chief scientific officer of Sarah Cannon Research Institute, Nashville, US, and will oversee the development and operations of Sarah Cannon’s clinical research program. Dr. Spigel joined Sarah Cannon in 2003 as the director of the lung cancer research program.
Sign up for news updates
Share this Article:
Recent Posts
-
August 11, 2026
-
August 11, 2026
-
August 11, 2026
-
August 11, 2026
View ILCN Archives
Provider Resources
Popular Articles
-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care